2022 FDA approvals

被引：56

作者：

Mullard, Asher

机构：

来源：

关键词：

D O I：

10.1038/d41573-023-00001-3

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The FDA approved 37 novel drugs in 2022, the fewest to pass regulatory scrutiny since 2016.

引用

页码：83 / 88

页数：6

共 50 条

[31] 2014 FDA drug approvals
Asher Mullard
[J]. Nature Reviews Drug Discovery, 2015, 14 : 77 - 81
[32] SIGNIFICANT FDA APPROVALS IN 1990
RHEINSTEIN, PH
[J]. AMERICAN FAMILY PHYSICIAN, 1991, 43 (06) : 2257 - 2258
[33] 2018 FDA drug approvals
Mullard, Asher
[J]. NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (02) : 85 - 89
[34] 2008 FDA drug approvals
Bethan Hughes
[J]. Nature Reviews Drug Discovery, 2009, 8 : 93 - 96
[35] 2009 FDA drug approvals
Bethan Hughes
[J]. Nature Reviews Drug Discovery, 2010, 9 : 89 - 92
[36] FDA and EMA Biosimilar Approvals
Emily H. Jung
Ameet Sarpatwari
Aaron S. Kesselheim
Michael S. Sinha
[J]. Journal of General Internal Medicine, 2020, 35 : 1908 - 1910
[37] 2015 FDA drug approvals
Mullard, Asher
[J]. NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (02) : 73 - 77
[38] FDA and EMA Biosimilar Approvals
Jung, Emily H.
Sarpatwari, Ameet
Kesselheim, Aaron S.
Sinha, Michael S.
[J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (06) : 1908 - 1910
[39] 2014 FDA drug approvals
Mullard, Asher
[J]. NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (02) : 77 - 81
[40] FDA approvals - Insulin injection
不详
[J]. GERIATRICS, 2000, 55 (08) : 16 - 16